Cabot Corp (NYSE:CBT) to Post Q1 2020 Earnings of $0.82 Per Share, SunTrust Banks Forecasts

Cabot Corp (NYSE:CBT) – Analysts at SunTrust Banks issued their Q1 2020 EPS estimates for Cabot in a report released on Tuesday, November 5th. SunTrust Banks analyst J. Sheehan forecasts that the specialty chemicals company will post earnings of $0.82 per share for the quarter. SunTrust Banks also issued estimates for Cabot’s Q2 2020 earnings at $0.95 EPS, Q3 2020 earnings at $0.99 EPS, Q4 2020 earnings at $1.03 EPS, FY2020 earnings at $3.79 EPS and FY2021 earnings at $4.05 EPS.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.05 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.11 by ($0.06). Cabot had a net margin of 4.70% and a return on equity of 19.06%. The firm had revenue of $827.00 million during the quarter, compared to analysts’ expectations of $849.44 million. During the same quarter last year, the business posted $1.00 EPS. The company’s quarterly revenue was down 2.7% on a year-over-year basis.

Several other equities research analysts have also issued reports on the stock. Northcoast Research set a $45.00 price target on shares of Cabot and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Loop Capital lowered shares of Cabot from a “buy” rating to a “hold” rating and decreased their price target for the stock from $69.00 to $41.00 in a research note on Monday, August 5th. Robert W. Baird lowered shares of Cabot from an “outperform” rating to a “neutral” rating and set a $45.00 price target for the company. in a research note on Wednesday, October 16th. TheStreet lowered shares of Cabot from a “b-” rating to a “c+” rating in a research note on Wednesday, August 14th. Finally, JPMorgan Chase & Co. lowered shares of Cabot from an “overweight” rating to a “neutral” rating and raised their price target for the stock from $40.00 to $45.00 in a research note on Wednesday. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $44.67.

Shares of CBT stock traded up $0.51 during trading hours on Friday, hitting $50.23. 433,529 shares of the company were exchanged, compared to its average volume of 359,349. The firm has a fifty day simple moving average of $44.86 and a 200 day simple moving average of $44.04. The company has a current ratio of 2.02, a quick ratio of 1.27 and a debt-to-equity ratio of 0.90. Cabot has a 52-week low of $37.11 and a 52-week high of $50.90. The stock has a market capitalization of $2.89 billion, a price-to-earnings ratio of 12.85, a P/E/G ratio of 1.30 and a beta of 1.52.

Hedge funds have recently modified their holdings of the company. Laurion Capital Management LP increased its stake in shares of Cabot by 60.5% during the 2nd quarter. Laurion Capital Management LP now owns 16,116 shares of the specialty chemicals company’s stock worth $769,000 after purchasing an additional 6,074 shares during the last quarter. Coastal Investment Advisors Inc. purchased a new position in Cabot in the 2nd quarter valued at approximately $57,000. Nisa Investment Advisors LLC grew its stake in Cabot by 6.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 8,900 shares of the specialty chemicals company’s stock valued at $403,000 after buying an additional 500 shares in the last quarter. Machina Capital S.A.S. grew its stake in Cabot by 409.2% in the 2nd quarter. Machina Capital S.A.S. now owns 998 shares of the specialty chemicals company’s stock valued at $48,000 after buying an additional 802 shares in the last quarter. Finally, Malaga Cove Capital LLC grew its stake in Cabot by 40.3% in the 3rd quarter. Malaga Cove Capital LLC now owns 19,474 shares of the specialty chemicals company’s stock valued at $883,000 after buying an additional 5,589 shares in the last quarter. Institutional investors own 86.10% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.

Recommended Story: What is the return on assets formula?

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply